KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Inventory (2016 - 2026)

Staar Surgical (STAA) has disclosed Inventory for 17 consecutive years, with $55.5 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Inventory rose 24.48% year-over-year to $55.5 million, compared with a TTM value of $55.5 million through Jan 2026, up 24.48%, and an annual FY2026 reading of $55.5 million, up 24.48% over the prior year.
  • Inventory was $55.5 million for Q1 2026 at Staar Surgical, up from $53.3 million in the prior quarter.
  • Across five years, Inventory topped out at $55.5 million in Q1 2026 and bottomed at $18.1 million in Q3 2022.
  • Average Inventory over 5 years is $37.0 million, with a median of $38.6 million recorded in 2023.
  • The sharpest move saw Inventory grew 7.51% in 2022, then skyrocketed 75.54% in 2023.
  • Year by year, Inventory stood at $25.8 million in 2022, then surged by 49.56% to $38.6 million in 2023, then increased by 15.39% to $44.6 million in 2024, then increased by 19.56% to $53.3 million in 2025, then increased by 4.12% to $55.5 million in 2026.
  • Business Quant data shows Inventory for STAA at $55.5 million in Q1 2026, $53.3 million in Q3 2025, and $53.1 million in Q2 2025.